Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

  • Technology appraisal guidance
  • TA209
  • Published: 
Download guidance (PDF)

Changes after publication

September 2013: correction to show that recommendation 1.5 in TA 86 had been updated, rather than recommendation 1.4.

March 2012: minor maintenance.